Healthcare Value Capital’s Antares Pharma, Inc. ATRS Stock Holding History

Healthcare Value Capital’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.82M	Hold	500,000	–	–	3.59%	15
2021 Q2	$2.18M	Hold	500,000	–	–	4.34%	12
2021 Q1	$2.06M	Hold	500,000	–	–	4.58%	11
2020 Q4	$2M	Hold	500,000	–	–	6.72%	6
2020 Q3	$1.35M	Hold	500,000	–	–	4.45%	10
2020 Q2	$1.38M	Hold	500,000	–	–	3.51%	15
2020 Q1	$1.18M	Buy	500,000 +200,000	+67%	+$680K	1.98%	19
2019 Q4	$1.41M	Buy	300,000 +100,000	+50%	+$409K	4.15%	10
2019 Q3	$669K	Buy	+200,000	New	+$659K	1.21%	20
2019 Q2	–	Sell	-250,000	Closed	-$723K	–	21
2019 Q1	$758K	Hold	250,000	–	–	2.92%	9
2018 Q4	$680K	Hold	250,000	–	–	2.64%	9
2018 Q3	$840K	Buy	250,000 +150,000	+150%	+$463K	2.03%	10
2018 Q2	$258K	Buy	+100,000	New	+$249K	0.73%	12

Other funds holding ATRS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Healthcare Value Capital's ATRS Position: Q3 2021 in Review

Healthcare Value Capital held its Antares Pharma, Inc. (ATRS) position steady in Q3 2021 at 500,000 shares worth $1.82M. The position accounts for 3.59% of the portfolio, ranked #15.

Healthcare Value Capital first reported a position in ATRS in Q2 2018 and has held it in 13 quarters since. The position peaked at $2.18M in Q2 2021. 170 funds tracked by Wall St. Rank hold ATRS as of Q3 2021.

Healthcare Value Capital held 500,000 shares of Antares Pharma, Inc. worth $1.82M as of Q3 2021.
Healthcare Value Capital left its Antares Pharma, Inc. share count unchanged in Q3 2021.
Antares Pharma, Inc. made up 3.59% of Healthcare Value Capital's portfolio in Q3 2021, its #15 holding.
Healthcare Value Capital first reported a position in Antares Pharma, Inc. in Q2 2018 and has held it in 13 quarters since.
Healthcare Value Capital's Antares Pharma, Inc. position peaked at $2.18M in Q2 2021.
170 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.